avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEIS2 | hg19_v2_chr15_-_37391507_37391604 | 0.39 | 9.3e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
2.3 | 16.3 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
2.3 | 6.9 | GO:0060595 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
2.0 | 10.0 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
2.0 | 23.8 | GO:0070487 | monocyte aggregation(GO:0070487) |
2.0 | 11.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.9 | 11.6 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
1.9 | 5.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.9 | 5.7 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.8 | 1.8 | GO:0060594 | mammary gland specification(GO:0060594) |
1.8 | 5.5 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
1.8 | 8.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.5 | 6.2 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
1.5 | 10.7 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
1.5 | 4.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.4 | 4.1 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
1.3 | 5.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.3 | 11.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.3 | 3.9 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
1.2 | 1.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.2 | 8.5 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
1.2 | 8.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.2 | 4.8 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.2 | 3.6 | GO:0021503 | neural fold bending(GO:0021503) |
1.2 | 3.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
1.1 | 2.3 | GO:0006788 | heme oxidation(GO:0006788) |
1.1 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.1 | 4.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.1 | 1.1 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.1 | 6.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.1 | 10.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.1 | 2.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
1.0 | 3.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
1.0 | 7.3 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
1.0 | 9.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.0 | 5.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
1.0 | 3.1 | GO:0008057 | eye pigment granule organization(GO:0008057) |
1.0 | 9.1 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 7.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.0 | 1.0 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
1.0 | 2.9 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
1.0 | 4.8 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.9 | 4.7 | GO:0032796 | uropod organization(GO:0032796) |
0.9 | 5.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.9 | 7.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.9 | 1.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.9 | 6.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.8 | 2.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.8 | 5.1 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.8 | 6.6 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.8 | 1.6 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.8 | 13.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 3.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.8 | 0.8 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.8 | 0.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.8 | 4.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 6.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.8 | 11.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 8.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.8 | 3.8 | GO:0070295 | renal water absorption(GO:0070295) |
0.8 | 3.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.7 | 2.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.7 | 2.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.7 | 8.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.7 | 2.9 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.7 | 4.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.7 | 2.2 | GO:1904301 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.7 | 2.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.7 | 3.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.7 | 2.8 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.7 | 2.8 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.7 | 19.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.7 | 2.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.7 | 2.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 5.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.7 | 7.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.7 | 2.7 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.7 | 4.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.7 | 2.0 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.7 | 0.7 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.7 | 6.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 3.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.7 | 2.0 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.6 | 2.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.6 | 3.8 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.6 | 5.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.6 | 0.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.6 | 7.6 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.6 | 6.3 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.6 | 3.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 0.6 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.6 | 1.2 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.6 | 9.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 4.3 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.6 | 4.8 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 10.8 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 1.8 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 7.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.6 | 4.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 2.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.6 | 2.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.6 | 2.8 | GO:0051620 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.6 | 1.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.6 | 2.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.5 | 2.7 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.5 | 2.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.5 | 4.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.5 | 3.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.5 | 3.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 2.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.5 | 9.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.5 | 3.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 2.1 | GO:0010193 | response to ozone(GO:0010193) |
0.5 | 2.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 6.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.5 | 2.0 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.5 | 3.0 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.5 | 3.0 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.5 | 6.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.5 | 2.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.5 | 0.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.5 | 2.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 33.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.5 | 17.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 4.8 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.5 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 3.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.5 | 2.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 2.4 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.5 | 0.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.5 | 1.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 9.3 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.5 | 5.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.5 | 1.8 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.5 | 1.8 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.5 | 1.4 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.5 | 2.7 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 1.3 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.4 | 3.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 1.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 2.6 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.4 | 2.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 2.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 4.3 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.4 | 5.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 2.6 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.4 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.7 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.4 | 2.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.4 | 2.5 | GO:2000096 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 5.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 16.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 0.4 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.4 | 4.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.4 | 2.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 1.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 1.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 0.8 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 1.6 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.4 | 2.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 2.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 5.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.4 | 3.6 | GO:0061053 | somite development(GO:0061053) |
0.4 | 2.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.4 | 1.6 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.4 | 0.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 2.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.4 | 2.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 2.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.4 | 2.4 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.4 | 4.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 2.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 2.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 1.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.4 | 5.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.4 | 3.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 2.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.4 | 1.1 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.4 | 1.9 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.4 | 10.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 0.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 1.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.4 | 1.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.4 | 1.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 1.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.4 | 2.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 2.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 1.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.4 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 4.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.4 | 0.7 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.4 | 1.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.4 | 0.4 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.4 | 1.4 | GO:0052214 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.4 | 1.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.4 | 0.7 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.4 | 3.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 0.7 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.3 | 1.7 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.3 | 2.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 1.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 5.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.7 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.3 | 1.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 1.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.7 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 2.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 1.0 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.3 | 1.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 2.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.7 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 3.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 1.6 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.3 | 2.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.3 | 2.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.3 | 1.3 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.3 | 2.0 | GO:0071422 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
0.3 | 0.6 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.9 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.3 | 1.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.3 | 1.6 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.3 | 3.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 2.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.3 | 0.9 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.3 | 3.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.3 | 4.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.6 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.3 | 4.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.3 | 2.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 0.6 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.3 | 0.9 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.3 | 0.9 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.3 | 2.7 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.3 | 1.5 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.3 | 2.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 0.9 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.3 | 0.9 | GO:0031247 | actin rod assembly(GO:0031247) |
0.3 | 2.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.2 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 3.6 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.3 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.3 | 5.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 1.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.6 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 1.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 1.2 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.3 | 4.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.9 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 0.9 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.3 | 4.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.9 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.3 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 6.6 | GO:0060004 | reflex(GO:0060004) |
0.3 | 0.9 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 1.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 1.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 2.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.3 | 5.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.3 | 1.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.3 | 1.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.9 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.3 | 5.6 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.3 | 4.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 1.1 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.3 | 1.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 | 0.8 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
0.3 | 1.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 5.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 1.3 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 1.6 | GO:0071543 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 0.8 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.3 | 12.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 2.1 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 2.1 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 1.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.3 | 0.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 2.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.3 | 1.5 | GO:0051414 | response to cortisol(GO:0051414) |
0.3 | 2.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.3 | 3.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 1.0 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 1.0 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.3 | 1.3 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 1.3 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.2 | 1.0 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.2 | 1.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 3.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 7.4 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 3.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.5 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine deoxyribonucleotide biosynthetic process(GO:0009153) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.2 | 1.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 2.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 2.4 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.2 | 1.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 3.3 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.2 | 0.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 1.6 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 0.9 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 0.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.2 | 0.7 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.2 | 1.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 0.5 | GO:1900368 | pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 1.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.9 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.2 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 2.5 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 1.1 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.1 | GO:2000836 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.2 | 0.2 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.2 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 10.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 2.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 3.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 2.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 3.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 1.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 1.1 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.2 | 1.5 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.2 | 0.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 3.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 0.7 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.2 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.9 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.7 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.2 | 0.6 | GO:0042245 | RNA repair(GO:0042245) |
0.2 | 0.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.2 | 1.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.4 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.2 | 2.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.2 | 1.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 0.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 | 0.8 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 1.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 2.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 3.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 1.0 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.2 | 1.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 5.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 3.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 0.4 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.2 | 1.8 | GO:0048332 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
0.2 | 4.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 2.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.6 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.2 | 1.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 7.0 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.2 | 0.4 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 2.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.2 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.8 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 0.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.2 | 1.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 3.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 2.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.2 | 14.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 10.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 0.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.9 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.2 | 0.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.7 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 1.1 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 3.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 6.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.2 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 2.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 1.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 20.5 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 1.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 2.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.9 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 0.7 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.2 | 0.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.2 | 0.5 | GO:1990709 | maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
0.2 | 0.3 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 1.0 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.2 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.2 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 2.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 1.2 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.2 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.5 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.2 | 0.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 0.7 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 17.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 3.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.5 | GO:1900222 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.5 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.2 | 1.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 1.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 0.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.2 | 4.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.3 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.2 | 0.5 | GO:0007538 | primary sex determination(GO:0007538) |
0.2 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.2 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.2 | 2.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.9 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.5 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 1.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 1.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 2.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 1.7 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 0.9 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.6 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.2 | 4.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 1.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 2.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 4.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 2.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 2.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 2.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.6 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 1.0 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 3.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 2.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.4 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.1 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 2.8 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.7 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.6 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 8.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.6 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 1.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.1 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 1.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.7 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.4 | GO:0070781 | response to biotin(GO:0070781) |
0.1 | 1.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 1.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 7.8 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 1.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.6 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.4 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0086054 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 2.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.8 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.5 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 2.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.4 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 5.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 1.6 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 1.7 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.8 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.1 | 1.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.4 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 1.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 1.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 5.1 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.4 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 2.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.6 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.4 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 2.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 3.0 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.6 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 1.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 3.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.4 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.8 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.1 | 0.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.1 | 0.4 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.1 | 1.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 1.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.1 | 0.7 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.3 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 1.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 2.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.3 | GO:0097112 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.5 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 3.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 1.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 1.5 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.9 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 1.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 1.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 5.4 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 0.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 3.8 | GO:0043623 | cellular protein complex assembly(GO:0043623) |
0.1 | 2.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:0051685 | endoplasmic reticulum localization(GO:0051643) maintenance of ER location(GO:0051685) |
0.1 | 0.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.4 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 2.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 2.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 2.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 1.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 1.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.7 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.4 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:1905063 | phenotypic switching(GO:0036166) metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) regulation of phenotypic switching(GO:1900239) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell differentiation(GO:1905063) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.1 | 5.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 1.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 2.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 1.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 5.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 1.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 0.7 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
0.1 | 1.0 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 1.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.4 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.1 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.8 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.7 | GO:1990539 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.1 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 1.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.7 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.1 | 7.2 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 | 9.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.9 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 1.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 1.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0098743 | cell aggregation(GO:0098743) |
0.1 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.3 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 1.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.5 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 1.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.7 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.6 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 8.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 8.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 7.1 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 4.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 2.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 2.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.7 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 2.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 2.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 3.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 2.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.7 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 1.2 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.5 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 1.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 | 0.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 4.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.7 | GO:0032324 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 3.7 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 1.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 1.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 2.3 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 2.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 7.0 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 1.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.3 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) snRNA import into nucleus(GO:0061015) |
0.1 | 0.5 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 1.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 2.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.1 | 0.9 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 1.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 1.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.6 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.1 | 2.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 1.0 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 1.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.3 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.2 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 2.9 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 3.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 4.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.4 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 1.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.4 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.9 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.2 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.1 | 0.5 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.4 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 2.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.3 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 2.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 1.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.3 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 1.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) formaldehyde catabolic process(GO:0046294) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 4.0 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 1.5 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.5 | GO:0051304 | chromosome separation(GO:0051304) |
0.0 | 0.1 | GO:1904247 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.0 | 0.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.1 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 1.1 | GO:0009251 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 2.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
0.0 | 0.2 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.0 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.5 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.0 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0009743 | response to carbohydrate(GO:0009743) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.9 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 1.3 | GO:0050890 | cognition(GO:0050890) |
0.0 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 1.2 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.7 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.0 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.9 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.3 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 2.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0072716 | response to actinomycin D(GO:0072716) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 3.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.2 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.0 | 2.2 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 2.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.3 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.0 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.0 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.7 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.2 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.3 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) actin nucleation(GO:0045010) |
0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 1.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0045553 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.0 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.1 | GO:0060073 | micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.0 | 0.4 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.0 | 0.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 1.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 1.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.0 | 0.3 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 1.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.3 | GO:0046323 | glucose import(GO:0046323) |
0.0 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.6 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
2.5 | 17.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
2.3 | 18.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.6 | 17.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.4 | 8.6 | GO:0031673 | H zone(GO:0031673) |
1.4 | 9.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.1 | 6.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.0 | 8.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.9 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 4.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.9 | 3.5 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.8 | 6.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.7 | 2.2 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.7 | 50.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.7 | 6.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 3.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.6 | 6.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 0.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 2.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.5 | 11.3 | GO:0042611 | MHC protein complex(GO:0042611) MHC class II protein complex(GO:0042613) |
0.5 | 1.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 2.6 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.5 | 7.8 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 3.0 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 3.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.5 | 1.5 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.5 | 2.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 2.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 1.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.5 | 0.9 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 6.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 1.8 | GO:0031592 | centrosomal corona(GO:0031592) |
0.4 | 1.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.4 | 4.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.4 | 4.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 3.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.4 | 5.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 10.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.4 | 6.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 10.3 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 2.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 6.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.4 | 2.2 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 5.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 2.9 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.4 | 4.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 2.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 1.0 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.3 | 2.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 4.6 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 6.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 0.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 1.0 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.3 | 10.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 2.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 3.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.6 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.3 | 2.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 9.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 10.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 8.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.3 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 7.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 2.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 15.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 3.9 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.8 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.3 | 0.8 | GO:0097444 | spine apparatus(GO:0097444) |
0.3 | 1.6 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 1.1 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.3 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 2.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 6.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 2.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 3.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.2 | 2.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 10.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 0.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 3.9 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 5.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.6 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 3.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 2.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 2.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 3.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 1.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 4.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.8 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.8 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 1.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 2.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.5 | GO:0075341 | host cell PML body(GO:0075341) |
0.2 | 4.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 5.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 3.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.5 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.2 | 0.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 4.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 1.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.0 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 1.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 28.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 0.5 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.2 | 1.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 1.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 29.6 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 6.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 4.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 17.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 3.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.4 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 4.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 6.3 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 1.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 2.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 5.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 20.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 3.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 2.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 10.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.4 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 3.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 5.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 28.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 2.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.6 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 0.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 7.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 11.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 3.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 3.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 1.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 5.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 8.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 2.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 14.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 11.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.6 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 1.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 3.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 6.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 1.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 3.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.3 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 2.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 2.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 0.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.5 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 7.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 27.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 5.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 9.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.6 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 2.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.3 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 2.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 1.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 1.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.0 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 2.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.0 | 4.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 1.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 5.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 0.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 5.6 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 2.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 11.3 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 14.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 4.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 5.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.6 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 4.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.0 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.7 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.5 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.8 | 22.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.7 | 2.7 | GO:0016722 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions(GO:0016722) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.9 | 5.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.7 | 11.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.6 | 6.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
1.4 | 5.8 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
1.4 | 6.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.4 | 13.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.3 | 6.4 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
1.2 | 3.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.1 | 3.4 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
1.1 | 4.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.1 | 3.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.1 | 5.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.1 | 3.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.0 | 22.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
1.0 | 8.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.0 | 4.1 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
1.0 | 1.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.0 | 3.8 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.9 | 12.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 11.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.8 | 2.5 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.8 | 12.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.8 | 4.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.7 | 3.7 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.7 | 2.9 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.7 | 10.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.7 | 14.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 4.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.7 | 9.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 4.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 2.0 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.7 | 15.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 2.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.7 | 2.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.6 | 27.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 2.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.6 | 10.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 3.6 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.6 | 3.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.6 | 1.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.6 | 2.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.6 | 3.4 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.6 | 2.3 | GO:1990175 | EH domain binding(GO:1990175) |
0.6 | 6.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 3.9 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.6 | 2.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.6 | 2.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 6.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 12.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 2.7 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.5 | 3.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.5 | 7.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.5 | 3.8 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.5 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 5.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 12.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 5.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 1.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.5 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 2.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.5 | 2.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.5 | 7.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 2.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.4 | 5.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.4 | 1.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.4 | 2.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 5.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 2.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 9.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 12.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 0.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 1.6 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.4 | 10.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.4 | 2.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 3.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 5.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 2.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 3.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 5.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.2 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.4 | 3.5 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 4.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 7.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 2.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 1.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.4 | 2.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 3.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.8 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.4 | 3.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.4 | 4.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.8 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 1.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 3.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 2.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 5.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.3 | 1.0 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.3 | 1.7 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.3 | 4.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 3.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.3 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.3 | 1.0 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.3 | 2.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 2.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.3 | 4.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.2 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 3.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 14.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.9 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 1.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 2.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 10.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 11.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.3 | 3.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 7.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 2.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.3 | 1.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 5.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.9 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.3 | 2.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.3 | GO:0052812 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.3 | 2.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.1 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.3 | 1.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 5.9 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.3 | 2.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 7.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 3.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 3.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.3 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 2.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 2.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 0.8 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.3 | 1.6 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.3 | 5.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 1.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.3 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 1.0 | GO:0004040 | amidase activity(GO:0004040) |
0.3 | 2.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 6.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.8 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.3 | 6.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 2.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 10.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 9.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 0.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.3 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 8.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 1.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 1.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 8.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 4.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 1.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 1.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.7 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.2 | 1.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 4.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 5.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 2.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.9 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.2 | 10.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 5.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 3.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 3.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.6 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 1.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.2 | 4.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 5.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 1.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.7 | GO:0000828 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 4.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 2.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.8 | GO:0004307 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.2 | 0.6 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.2 | 4.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 58.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 3.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 5.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 3.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.8 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 2.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 1.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 7.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.8 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.2 | 1.5 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.2 | 2.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 2.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 1.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.5 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 2.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.2 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.0 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.2 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 3.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 12.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 2.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.5 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.2 | 4.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 3.9 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 0.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 1.9 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 10.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 1.2 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.2 | 1.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 0.5 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.2 | 4.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.4 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.1 | 2.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 4.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 2.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 2.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 5.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 3.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 5.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 6.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 28.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 3.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 6.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 2.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 3.7 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.4 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 2.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.8 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 4.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 2.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 1.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 2.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.4 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.1 | 0.6 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 3.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.3 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 2.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 5.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 2.5 | GO:0008253 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 0.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.5 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 0.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 1.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 2.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.8 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 1.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 2.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 2.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 9.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 4.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 2.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 1.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 2.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.7 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 3.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 4.0 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 1.4 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.4 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.1 | 5.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 0.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.1 | 7.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.1 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 1.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 2.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 4.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 5.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 2.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 11.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 0.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.1 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0046977 | peptide antigen-transporting ATPase activity(GO:0015433) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.1 | 0.3 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 1.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 1.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 1.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 4.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 3.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 4.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 1.8 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 3.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 2.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 1.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 2.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 5.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.1 | 3.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.8 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 4.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.5 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 7.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 3.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 1.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 10.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.3 | GO:0023029 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding(GO:0023029) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 4.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 1.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 10.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 2.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 12.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 4.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.0 | 1.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 2.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.4 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 17.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 1.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 59.5 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.9 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 1.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 1.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.2 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.0 | 0.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 10.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.0 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.0 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.9 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 0.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 2.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 24.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 17.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 2.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 13.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 25.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 17.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 10.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 2.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 1.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 16.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 8.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 10.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 7.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 11.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 17.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 6.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 4.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 13.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 20.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 5.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 6.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 3.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 18.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 12.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 6.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 16.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 4.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 4.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 4.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 4.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 14.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 4.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 10.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 6.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 3.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 5.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 4.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 13.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 3.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 6.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.8 | 16.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 12.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 7.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 8.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 2.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 4.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 11.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 10.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 13.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 11.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 3.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 7.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 6.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 6.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 14.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 4.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 5.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 6.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 12.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 6.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 5.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 2.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 11.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 3.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 3.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 6.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 9.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 6.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 6.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 2.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 4.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 6.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 7.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 4.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 5.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 6.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 3.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 11.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 10.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 3.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 2.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 2.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 2.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 4.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 5.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 7.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 4.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 8.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 17.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 12.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 4.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 7.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 3.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 7.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 3.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 4.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 14.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 8.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 8.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 5.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 45.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 4.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.5 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 0.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 4.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 1.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 3.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 2.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 6.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.7 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 4.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.8 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |